NO20013978L - Dopamin D1 reseptor agonist forbindelser - Google Patents
Dopamin D1 reseptor agonist forbindelserInfo
- Publication number
- NO20013978L NO20013978L NO20013978A NO20013978A NO20013978L NO 20013978 L NO20013978 L NO 20013978L NO 20013978 A NO20013978 A NO 20013978A NO 20013978 A NO20013978 A NO 20013978A NO 20013978 L NO20013978 L NO 20013978L
- Authority
- NO
- Norway
- Prior art keywords
- dopamine
- receptor agonist
- agonist compounds
- compounds
- receptor
- Prior art date
Links
- 229940098305 Dopamine D1 receptor agonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000510 dopamine 1 receptor stimulating agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903671.7A GB9903671D0 (en) | 1999-02-17 | 1999-02-17 | Dopamine D-1 receptor agonist compounds |
| PCT/GB2000/000570 WO2000049000A1 (en) | 1999-02-17 | 2000-02-17 | Dopamine d1 receptor agonist compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013978D0 NO20013978D0 (no) | 2001-08-15 |
| NO20013978L true NO20013978L (no) | 2001-08-15 |
Family
ID=10847990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013978A NO20013978L (no) | 1999-02-17 | 2001-08-15 | Dopamin D1 reseptor agonist forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1157009A1 (no) |
| JP (1) | JP2002537288A (no) |
| KR (1) | KR20010108228A (no) |
| CN (1) | CN1142916C (no) |
| AU (1) | AU767332B2 (no) |
| BR (1) | BR0008329A (no) |
| CA (1) | CA2363695A1 (no) |
| CZ (1) | CZ20012973A3 (no) |
| EA (1) | EA004745B1 (no) |
| GB (1) | GB9903671D0 (no) |
| HU (1) | HUP0200057A3 (no) |
| IL (1) | IL144810A0 (no) |
| MX (1) | MXPA01008294A (no) |
| NO (1) | NO20013978L (no) |
| PL (1) | PL349838A1 (no) |
| WO (1) | WO2000049000A1 (no) |
| ZA (1) | ZA200106478B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
| EA019115B1 (ru) * | 2005-07-15 | 2014-01-30 | Олбани Молекьюлар Рисерч, Инк. | Арил- и гетероарилзамещенные тетрагидробензазепины и их применение для блокировки обратного захвата норэпинефрина, допамина и серотонина |
| JP2009502206A (ja) * | 2005-08-03 | 2009-01-29 | ミニュー・セラピューティクス・リミテッド | 腫瘍壊死因子アルファ（ＴＮＦ−α）合成および分泌を調節するための、Ｔ細胞におけるＫｖ１．１電位依存性カリウムチャンネルのモデュレーション、およびＴＮＦ−αの有害な高または低レベルを介しての人の疾患または傷害の治療 |
| CN101684096A (zh) * | 2008-09-23 | 2010-03-31 | 中国科学院上海药物研究所 | 一类新型苯并氮杂卓类化合物及其制备方法和用途 |
| CN102276531A (zh) * | 2011-05-30 | 2011-12-14 | 扬子江药业集团广州海瑞药业有限公司 | 一种甲磺酸非诺多泮的制备方法 |
| CA2916653C (en) | 2013-06-27 | 2017-07-18 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561305A (en) * | 1975-07-02 | 1980-02-20 | Smithkline Corp | Benzazepine derivatives and pharmeceutical compositions containing them |
| US4111957A (en) * | 1977-02-02 | 1978-09-05 | Smithkline Corporation | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| US4265889A (en) * | 1978-05-05 | 1981-05-05 | Smithkline Corporation | 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| US4861771A (en) * | 1989-01-27 | 1989-08-29 | Smithkline Beckman Corporation | Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs |
-
1999
- 1999-02-17 GB GBGB9903671.7A patent/GB9903671D0/en not_active Ceased
-
2000
- 2000-02-17 JP JP2000599740A patent/JP2002537288A/ja active Pending
- 2000-02-17 EA EA200100783A patent/EA004745B1/ru not_active IP Right Cessation
- 2000-02-17 CZ CZ20012973A patent/CZ20012973A3/cs unknown
- 2000-02-17 KR KR1020017010418A patent/KR20010108228A/ko not_active Withdrawn
- 2000-02-17 BR BR0008329-1A patent/BR0008329A/pt not_active IP Right Cessation
- 2000-02-17 CN CNB00803947XA patent/CN1142916C/zh not_active Expired - Fee Related
- 2000-02-17 HU HU0200057A patent/HUP0200057A3/hu unknown
- 2000-02-17 PL PL00349838A patent/PL349838A1/xx not_active Application Discontinuation
- 2000-02-17 EP EP00903881A patent/EP1157009A1/en not_active Withdrawn
- 2000-02-17 IL IL14481000A patent/IL144810A0/xx unknown
- 2000-02-17 WO PCT/GB2000/000570 patent/WO2000049000A1/en not_active Ceased
- 2000-02-17 MX MXPA01008294A patent/MXPA01008294A/es unknown
- 2000-02-17 AU AU25632/00A patent/AU767332B2/en not_active Ceased
- 2000-02-17 CA CA002363695A patent/CA2363695A1/en not_active Abandoned
-
2001
- 2001-08-07 ZA ZA200106478A patent/ZA200106478B/en unknown
- 2001-08-15 NO NO20013978A patent/NO20013978L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002537288A (ja) | 2002-11-05 |
| EA004745B1 (ru) | 2004-08-26 |
| EA200100783A1 (ru) | 2002-02-28 |
| CN1142916C (zh) | 2004-03-24 |
| CN1341102A (zh) | 2002-03-20 |
| HUP0200057A3 (en) | 2004-03-29 |
| AU767332B2 (en) | 2003-11-06 |
| WO2000049000A1 (en) | 2000-08-24 |
| CA2363695A1 (en) | 2000-08-24 |
| IL144810A0 (en) | 2002-06-30 |
| NO20013978D0 (no) | 2001-08-15 |
| BR0008329A (pt) | 2002-01-29 |
| AU2563200A (en) | 2000-09-04 |
| ZA200106478B (en) | 2002-02-07 |
| PL349838A1 (en) | 2002-09-23 |
| MXPA01008294A (es) | 2002-07-02 |
| KR20010108228A (ko) | 2001-12-07 |
| CZ20012973A3 (cs) | 2002-01-16 |
| HUP0200057A2 (en) | 2002-08-28 |
| GB9903671D0 (en) | 1999-04-14 |
| EP1157009A1 (en) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1189916T3 (da) | N-pyrazol A 2A-receptoragonister | |
| DK1446379T3 (da) | Arylanilin-beta2-adrenergiske receptoragonister | |
| ATE366729T1 (de) | Triazolverbindungen mit dopamin-d3- rezeptoraffinität | |
| DE69903953D1 (de) | 2-substituierte-1-piperidyl-benzimidazolverbindungen als orl1 rezeptor agonisten | |
| DE60132799D1 (de) | Peroxisom proliferator aktivierten rezeptor alpha agonisten | |
| DE60018989D1 (de) | N-carbamoyloxyalkyl-substituierte azolium-verbindungen | |
| ATE388937T1 (de) | Agonisten des cannabinoidrezeptors | |
| PT1347760E (pt) | Composicoes farmaceuticas de agonista do receptor de nmda | |
| NO20042737L (no) | Peroksisomproliferatoraktiverte receptoragonister | |
| NO20013997D0 (no) | Reseptoranalyse | |
| NO20016077L (no) | Makrofag-oppfanger-reseptorantagonister | |
| NO20016053L (no) | IL-8 reseptor-antagonister | |
| ID26086A (id) | Ligan-ligan reseptor 5ht1 azabisiklik | |
| MA26890A1 (fr) | Metabolites agonistes/ antagonistes d'oestrogenes | |
| DE60130000D1 (de) | Zwitterionische tachykinin-rezeptor-antagonisten | |
| NO20016052L (no) | IL-8-reseptor-antagonister | |
| DK1146874T3 (da) | Vitronectinreceptoragonist | |
| ATE352299T1 (de) | Il-8 rezeptorantagonist | |
| NO20013978D0 (no) | Dopamin D1 reseptor agonist forbindelser | |
| ATE264301T1 (de) | Muscarin-antagonisten | |
| NO20015774D0 (no) | IL-8 reseptorantagonister | |
| NO20021295L (no) | Nikotinsyreacetylcholin-reseptor | |
| GB0130576D0 (en) | Dopamine D1 receptor agonist pro-drug compounds & derivatives | |
| NO20016065D0 (no) | IL-8-reseptor-antagonister | |
| DK1207159T3 (da) | Heteroaromatiske derivater som dopamin-D4-receptorantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |